NCT01860781View on ClinicalTrials.gov

The Effect of Paliperidone Palmitate in Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Schizophrenia
Interventions
DRUG

paliperidone palmitate

paliperidone palmitate 150mgeq(1 day), 100mgeq(8days), 75mg(monthly)

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01860781 - The Effect of Paliperidone Palmitate in Schizophrenia | Biotech Hunter | Biotech Hunter